BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1814738)

  • 1. In vivo behaviour of low molecular weight iron complexes.
    Anghileri LJ; Cordova Martinez A; Maincent P; Robert J
    Eur J Drug Metab Pharmacokinet; 1991; 16(3):203-6. PubMed ID: 1814738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotoxicity of parenterally administered iron complexes.
    Anghileri LJ; Maincent P; Thouvenot P
    Arzneimittelforschung; 1995 Jun; 45(6):679-81. PubMed ID: 7646569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soft tissue calcification induced by iron complexes.
    Anghileri LJ
    Calcif Tissue Int; 1992 Jul; 51(1):83-4. PubMed ID: 1393784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo distribution of ferric-ATP complex.
    Anghileri LJ; Robert J
    Eur J Drug Metab Pharmacokinet; 1994; 19(1):1-3. PubMed ID: 7957445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in calcium uptake by liver induced by ferric lactate.
    Anghileri LJ; Maleki P; Robert J
    Arch Biochem Biophys; 1992 Feb; 292(2):529-33. PubMed ID: 1531001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of a ferric maltol complex and its subsequent metabolism during absorption across the small intestine of the rat.
    Barrand MA; Callingham BA; Dobbin P; Hider RC
    Br J Pharmacol; 1991 Mar; 102(3):723-9. PubMed ID: 1364845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative histochemistry for macrophage biodistribution on mice liver and spleen after the administration of a pharmacological-relevant dose of polyacrylic acid-coated iron oxide nanoparticles.
    Rodrigues D; Freitas M; Marisa Costa V; Arturo Lopez-Quintela M; Rivas J; Freitas P; Carvalho F; Fernandes E; Silva P
    Nanotoxicology; 2017 Mar; 11(2):256-266. PubMed ID: 28166432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron absorption by human subjects from different iron fortification compounds added to Thai fish sauce.
    Walczyk T; Tuntipopipat S; Zeder C; Sirichakwal P; Wasantwisut E; Hurrell RF
    Eur J Clin Nutr; 2005 May; 59(5):668-74. PubMed ID: 15756294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver calcium homeostasis modification by iron: a probable factor in its carcinogenesis.
    Anghileri LJ; Maincent P; Thouvenot P; Cordova-Martinez A
    Neoplasma; 1994; 41(4):221-3. PubMed ID: 7935996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of toxicity and oxidative stress induced by intravenous iron isomaltoside 1000 in a nonclinical model.
    Toblli JE; Cao G; Oliveri L; Angerosa M
    Arzneimittelforschung; 2011; 61(10):553-65. PubMed ID: 22164963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxicity in rats fed diet containing iron lactate for 26 weeks].
    Takegawa K; Yasuhara K; Mitsumori K; Onodera H; Shimo T; Takahashi M
    Eisei Shikenjo Hokoku; 1995; (113):58-63. PubMed ID: 8717229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between tissue uptake of lead and iron in normal and iron-deficient rats during development.
    Crowe A; Morgan EH
    Biol Trace Elem Res; 1996 Jun; 52(3):249-61. PubMed ID: 8811282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the retention in chicks and mice of 59Fe given orally as chloride, ethylene diamine tetra-acetate or nitrilotriacetate and in chicks given diets composed of conventional ingredients or semi-purified nutrients.
    Leighton MJ; Bhabuta A; Hill R
    Res Vet Sci; 1990 Sep; 49(2):138-43. PubMed ID: 2122505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of citrate and iron citrate uptake by cultured rat hepatocytes.
    Graham RM; Morgan EH; Baker E
    J Hepatol; 1998 Oct; 29(4):603-13. PubMed ID: 9824270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic aggregation and experimental brain tumors' uptake of 51Cr-beta-glycerophosphate.
    Anghileri LJ
    J Nucl Biol Med; 1968; 12(3):128-33. PubMed ID: 5732952
    [No Abstract]   [Full Text] [Related]  

  • 16. Differing effects of two iron compounds on experimental arthritis, TNF-alpha levels and immune response in mice.
    Poljak-Blazi M; Hrvacić B; Zupanović Z; Hadzija M; Stanić B; Polancec D
    Int Immunopharmacol; 2003 Dec; 3(13-14):1743-9. PubMed ID: 14636825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal absorption of cationic and anionic ferric colloids and complexes: biochemical, histochemical and morphological observations in rats.
    Akita M; Seno S; Awai M
    Nihon Ketsueki Gakkai Zasshi; 1990 Feb; 53(1):1-13. PubMed ID: 2330802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes.
    Heinrich HC
    Arzneimittelforschung; 1975 Mar; 25(3):420-6. PubMed ID: 1174047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperlactataemia, hyperkalemia and heart block in acute iron overload: the fatal role of the hepatic iron-incorporation rate in rats on ferric citrate infusions.
    Rosenmund A; Brand B; Straub PW
    Eur J Clin Invest; 1988 Feb; 18(1):69-74. PubMed ID: 3130262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron-tumor cell interaction and regulation of Ca2+ homeostasis: their implication in tumor growth.
    Anghileri LJ; Martinez AC; Maleki P
    Neoplasma; 1992; 39(3):157-61. PubMed ID: 1528320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.